NH stock news on Anadi Algo News

Tuesday, May 5, 2026
DISCLAIMER: AI-generated signals are for informational purposes only. All trading and investment decisions are solely the user's responsibility.|Past performance does not guarantee future results. Trade at your own risk.|Anadi Algo is not a SEBI-registered advisor. Consult a qualified financial advisor before acting on any recommendation.|DISCLAIMER: AI-generated signals are for informational purposes only. All trading and investment decisions are solely the user's responsibility.|Past performance does not guarantee future results. Trade at your own risk.|Anadi Algo is not a SEBI-registered advisor. Consult a qualified financial advisor before acting on any recommendation.|
Stock Landing|2 matching stories

NH Share Price, Latest News & Sentiment

Latest AI-analyzed news for NH, along with saved share-price context, sentiment, quarterly filing summary, and related names in one page.

Stock Coverage Hub

NH News Today

Emerging stock coverage

Nithin Kamath's observation highlights a perceived valuation disparity between essential healthcare services and financial brokerage firms in India. While not directly impacting stock prices, it sparks a debate on market efficiency and societal value, potentially influencing long-term investment theses for both sectors.

Coverage
2
recent stories
Sources
2
distinct publishers
Bias Split
0 bullish / 0 bearish
2 neutral stories
Window
3d
recent coverage span
Saved Quote Snapshot

Narayana Hrudayalaya Ltd.

Last Updated
4 May 2026
Price
Rs 1,772
+0.09%
52W Range
Rs 1,589 - Rs 2,370.2
exchange snapshot
PE / VWAP
PE 46.36
VWAP Rs 1,762.86
Trend Read
mixed
EMA stack mixed
Business Context
Industry: Hospital
Sector Trail: NIFTY SMALLCAP 100
Listing Date: 2016-01-06
Market Structure
F&O Eligible: No
Indices: NIFTY SMALLCAP 100, NIFTY500 MULTICAP MOMENTUM QUALITY 50, NIFTY ALPHA 50
Snapshot Source: mcp+nse
Quarterly Read

Quarter ended 30 Sept 2024

Non-Consolidated results
What This Quarter Says

This is the first public financial report for NH. The company reported sales of Rs 934.29 crore and a profit of Rs 105.53 crore. This information helps you understand how much money the company is making and spending.

Revenue
Rs 934.29 cr
down 33.3% vs previous filing
Profit
Rs 105.53 cr
down 46.9% vs previous filing
EPS / Finance Cost
EPS 5.2
Finance cost Rs 20.45 cr
Filing Context
Filed 1 Nov 2024, 2:06 am
Figures are taken from the saved exchange filing, not from a live request.
Quick Reader Notes
  • Revenue this quarter: Rs 934.29 cr, down 33.3% vs previous filing.
  • Profit this quarter: Rs 105.53 cr, down 46.9% vs previous filing.
  • EPS gives a quick sense of per-share earnings: 5.2.
How To Read This

Treat this block as a saved quarter snapshot. First see whether revenue and profit are improving, then read the latest news below to judge whether recent headlines support that trend or work against it.

Related Stocks

Peer names will show up here once more related-stock mentions appear in coverage.

NH FAQ

Why is NH in the news right now?

NH has appeared across 2 recent stories from 2 sources, which usually means there is a real flow of fresh headlines rather than a single isolated mention.

Is NH coverage bullish or bearish right now?

NH coverage is currently mixed, with 0 bullish, 0 bearish, and 2 neutral analyzed stories in the recent window.

Which themes are moving with NH?

Recent NH coverage is clustering around Construction and Financial Services. Related names showing up alongside NH include the wider peer basket.

How should I use this NH news page?

Use this page as a coverage hub for NH: start with the latest headlines, then check the dominant themes, related names, and saved market context before you form a trade or watchlist view.

Workflow View

Use NH coverage to build a cleaner watchlist.

A stock page is most useful when it helps you slow down, compare headlines, and separate one-off noise from a repeatable setup.

This is here if you want to go deeper, not as a push.Explore Anadi
This is a philosophical observation, not a direct trading signal; however, it prompts a re-evaluation of long-term investment strategies in healthcare versus financial services, focusing on intrinsic value.